Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Neurofibromatosis-2 » Country Statistics
 

Statistics by Country for Neurofibromatosis-2

Prevalance of Neurofibromatosis-2:

1 per 25,000 people suffer from neurofibromatosis type 2, Genetics Home Reference website

Prevalance Rate for Neurofibromatosis-2:

approx 1 in 25,000 or 0.00% or 10,880 people in USA [about data]

Extrapolation of Prevalence Rate of Neurofibromatosis-2 to Countries and Regions:

WARNING! EXTRAPOLATION ONLY! NOT BASED ON COUNTRY-SPECIFIC DATA SOURCES. The following table attempts to extrapolate the above prevalence rate for Neurofibromatosis-2 to the populations of various countries and regions. These prevalence extrapolations for Neurofibromatosis-2 are only estimates, based on applying the prevalence rates from the US (or a similar country) to the population of other countries, and therefore may have very limited relevance to the actual prevalence of Neurofibromatosis-2 in any region:

Country/Region Extrapolated Prevalence Population Estimated Used
Neurofibromatosis-2 in North America (Extrapolated Statistics)
USA 11,746 293,655,4051
Canada 1,300 WARNING! (Details) 32,507,8742
Mexico 4,198 WARNING! (Details) 104,959,5942
Neurofibromatosis-2 in Central America (Extrapolated Statistics)
Belize 10 WARNING! (Details) 272,9452
Guatemala 571 WARNING! (Details) 14,280,5962
Nicaragua 214 WARNING! (Details) 5,359,7592
Neurofibromatosis-2 in Caribbean (Extrapolated Statistics)
Puerto Rico 155 WARNING! (Details) 3,897,9602
Neurofibromatosis-2 in South America (Extrapolated Statistics)
Brazil 7,364 WARNING! (Details) 184,101,1092
Chile 632 WARNING! (Details) 15,823,9572
Colombia 1,692 WARNING! (Details) 42,310,7752
Paraguay 247 WARNING! (Details) 6,191,3682
Peru 1,101 WARNING! (Details) 27,544,3052
Venezuela 1,000 WARNING! (Details) 25,017,3872
Neurofibromatosis-2 in Northern Europe (Extrapolated Statistics)
Denmark 216 WARNING! (Details) 5,413,3922
Finland 208 WARNING! (Details) 5,214,5122
Iceland 11 WARNING! (Details) 293,9662
Sweden 359 WARNING! (Details) 8,986,4002
Neurofibromatosis-2 in Western Europe (Extrapolated Statistics)
Britain (United Kingdom) 2,410 WARNING! (Details) 60,270,708 for UK2
Belgium 413 WARNING! (Details) 10,348,2762
France 2,416 WARNING! (Details) 60,424,2132
Ireland 158 WARNING! (Details) 3,969,5582
Luxembourg 18 WARNING! (Details) 462,6902
Monaco 1 WARNING! (Details) 32,2702
Netherlands (Holland) 652 WARNING! (Details) 16,318,1992
United Kingdom 2,410 WARNING! (Details) 60,270,7082
Wales 116 WARNING! (Details) 2,918,0002
Neurofibromatosis-2 in Central Europe (Extrapolated Statistics)
Austria 326 WARNING! (Details) 8,174,7622
Czech Republic 49 WARNING! (Details) 1,0246,1782
Germany 3,296 WARNING! (Details) 82,424,6092
Hungary 401 WARNING! (Details) 10,032,3752
Liechtenstein 1 WARNING! (Details) 33,4362
Poland 1,545 WARNING! (Details) 38,626,3492
Slovakia 216 WARNING! (Details) 5,423,5672
Slovenia 80 WARNING! (Details) 2,011,473 2
Switzerland 298 WARNING! (Details) 7,450,8672
Neurofibromatosis-2 in Eastern Europe (Extrapolated Statistics)
Belarus 412 WARNING! (Details) 10,310,5202
Estonia 53 WARNING! (Details) 1,341,6642
Latvia 92 WARNING! (Details) 2,306,3062
Lithuania 144 WARNING! (Details) 3,607,8992
Russia 5,758 WARNING! (Details) 143,974,0592
Ukraine 1,909 WARNING! (Details) 47,732,0792
Neurofibromatosis-2 in the Southwestern Europe (Extrapolated Statistics)
Azerbaijan 314 WARNING! (Details) 7,868,3852
Georgia 187 WARNING! (Details) 4,693,8922
Portugal 420 WARNING! (Details) 10,524,1452
Spain 1,611 WARNING! (Details) 40,280,7802
Neurofibromatosis-2 in Southern Europe (Extrapolated Statistics)
Greece 425 WARNING! (Details) 10,647,5292
Italy 2,322 WARNING! (Details) 58,057,4772
Neurofibromatosis-2 in the Southeastern Europe (Extrapolated Statistics)
Albania 141 WARNING! (Details) 3,544,8082
Bosnia and Herzegovina 16 WARNING! (Details) 407,6082
Bulgaria 300 WARNING! (Details) 7,517,9732
Croatia 179 WARNING! (Details) 4,496,8692
Macedonia 81 WARNING! (Details) 2,040,0852
Romania 894 WARNING! (Details) 22,355,5512
Serbia and Montenegro 433 WARNING! (Details) 10,825,9002
Neurofibromatosis-2 in Northern Asia (Extrapolated Statistics)
Mongolia 110 WARNING! (Details) 2,751,3142
Neurofibromatosis-2 in Central Asia (Extrapolated Statistics)
Kazakhstan 605 WARNING! (Details) 15,143,7042
Tajikistan 280 WARNING! (Details) 7,011,556 2
Uzbekistan 1,056 WARNING! (Details) 26,410,4162
Neurofibromatosis-2 in Eastern Asia (Extrapolated Statistics)
China 51,953 WARNING! (Details) 1,298,847,6242
Hong Kong s.a.r. 274 WARNING! (Details) 6,855,1252
Japan 5,093 WARNING! (Details) 127,333,0022
Macau s.a.r. 17 WARNING! (Details) 445,2862
North Korea 907 WARNING! (Details) 22,697,5532
South Korea 1,929 WARNING! (Details) 48,233,7602
Taiwan 909 WARNING! (Details) 22,749,8382
Neurofibromatosis-2 in Southwestern Asia (Extrapolated Statistics)
Turkey 2,755 WARNING! (Details) 68,893,9182
Neurofibromatosis-2 in Southern Asia (Extrapolated Statistics)
Afghanistan 1,140 WARNING! (Details) 28,513,6772
Bangladesh 5,653 WARNING! (Details) 141,340,4762
Bhutan 87 WARNING! (Details) 2,185,5692
India 42,602 WARNING! (Details) 1,065,070,6072
Pakistan 6,367 WARNING! (Details) 159,196,3362
Sri Lanka 796 WARNING! (Details) 19,905,1652
Neurofibromatosis-2 in Southeastern Asia (Extrapolated Statistics)
East Timor 40 WARNING! (Details) 1,019,2522
Indonesia 9,538 WARNING! (Details) 238,452,9522
Laos 242 WARNING! (Details) 6,068,1172
Malaysia 940 WARNING! (Details) 23,522,4822
Philippines 3,449 WARNING! (Details) 86,241,6972
Singapore 174 WARNING! (Details) 4,353,8932
Thailand 2,594 WARNING! (Details) 64,865,5232
Vietnam 3,306 WARNING! (Details) 82,662,8002
Neurofibromatosis-2 in the Middle East (Extrapolated Statistics)
Gaza strip 52 WARNING! (Details) 1,324,9912
Iran 2,700 WARNING! (Details) 67,503,2052
Iraq 1,014 WARNING! (Details) 25,374,6912
Israel 247 WARNING! (Details) 6,199,0082
Jordan 224 WARNING! (Details) 5,611,2022
Kuwait 90 WARNING! (Details) 2,257,5492
Lebanon 151 WARNING! (Details) 3,777,2182
Saudi Arabia 1,031 WARNING! (Details) 25,795,9382
Syria 720 WARNING! (Details) 18,016,8742
United Arab Emirates 100 WARNING! (Details) 2,523,9152
West Bank 92 WARNING! (Details) 2,311,2042
Yemen 800 WARNING! (Details) 20,024,8672
Neurofibromatosis-2 in Northern Africa (Extrapolated Statistics)
Egypt 3,044 WARNING! (Details) 76,117,4212
Libya 225 WARNING! (Details) 5,631,5852
Sudan 1,565 WARNING! (Details) 39,148,1622
Neurofibromatosis-2 in Western Africa (Extrapolated Statistics)
Congo Brazzaville 119 WARNING! (Details) 2,998,0402
Ghana 830 WARNING! (Details) 20,757,0322
Liberia 135 WARNING! (Details) 3,390,6352
Niger 454 WARNING! (Details) 11,360,5382
Nigeria 710 WARNING! (Details) 12,5750,3562
Senegal 434 WARNING! (Details) 10,852,1472
Sierra leone 235 WARNING! (Details) 5,883,8892
Neurofibromatosis-2 in Central Africa (Extrapolated Statistics)
Central African Republic 149 WARNING! (Details) 3,742,4822
Chad 381 WARNING! (Details) 9,538,5442
Congo kinshasa 2,332 WARNING! (Details) 58,317,0302
Rwanda 329 WARNING! (Details) 8,238,6732
Neurofibromatosis-2 in Eastern Africa (Extrapolated Statistics)
Ethiopia 2,853 WARNING! (Details) 71,336,5712
Kenya 1,319 WARNING! (Details) 32,982,1092
Somalia 332 WARNING! (Details) 8,304,6012
Tanzania 1,442 WARNING! (Details) 36,070,7992
Uganda 1,055 WARNING! (Details) 26,390,2582
Neurofibromatosis-2 in Southern Africa (Extrapolated Statistics)
Angola 439 WARNING! (Details) 10,978,5522
Botswana 65 WARNING! (Details) 1,639,2312
South Africa 1,777 WARNING! (Details) 44,448,4702
Swaziland 46 WARNING! (Details) 1,169,2412
Zambia 441 WARNING! (Details) 11,025,6902
Zimbabwe 146 WARNING! (Details) 1,2671,8602
Neurofibromatosis-2 in Oceania (Extrapolated Statistics)
Australia 796 WARNING! (Details) 19,913,1442
New Zealand 159 WARNING! (Details) 3,993,8172
Papua New Guinea 216 WARNING! (Details) 5,420,2802

About extrapolations of prevalence and incidence statistics for Neurofibromatosis-2:

WARNING! EXTRAPOLATED STATISTICS ONLY! Not based on data sources from individual countries. These statistics are calculated extrapolations of various prevalence or incidence rates against the populations of a particular country or region. The statistics used for prevalence/incidence of Neurofibromatosis-2 are typically based on US, UK, Canadian or Australian prevalence or incidence statistics, which are then extrapolated using only the population of the other country. This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences across the various countries and regions for which the extrapolated Neurofibromatosis-2 statistics below refer to. The extrapolation does not use data sources or statistics about any country other than its population. As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication) as to the actual prevalence or incidence of Neurofibromatosis-2 in that region. These statistics are presented only in the hope that they may be interesting to some people.

About prevalence and incidence statistics in general for Neurofibromatosis-2:

The word 'prevalence' of Neurofibromatosis-2 usually means the estimated population of people who are managing Neurofibromatosis-2 at any given time (i.e. people with Neurofibromatosis-2). The term 'incidence' of Neurofibromatosis-2 means the annual diagnosis rate, or the number of new cases of Neurofibromatosis-2 diagnosed each year (i.e. getting Neurofibromatosis-2). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.



Footnotes:
1. US Census Bureau, Population Estimates, 2004
2. US Census Bureau, International Data Base, 2004
 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise